Tg Therapeutics, INC. (TGTX) — SC 13G/A Filings
All SC 13G/A filings from Tg Therapeutics, INC.. Browse 6 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (6)
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Oct 7, 2024
- SC 13G/A Filing — Feb 14, 2024
-
Vanguard Group Maintains Significant Passive Stake in TG Therapeutics
— Feb 13, 2024 Risk: low
The Vanguard Group, a major investment firm, filed an amended SC 13G/A on February 13, 2024, indicating its ownership of TG Therapeutics Inc. common stock as of -
BlackRock Amends TG Therapeutics Stake, Signals Position Update
— Jan 26, 2024
BlackRock Inc. filed an amended SC 13G/A on January 26, 2024, indicating its ownership of TG Therapeutics, Inc. common stock as of December 31, 2023. This amend -
State Street Corp Amends TG Therapeutics Stake, Remains Passive Investor
— Jan 25, 2024
State Street Corp, a major financial institution, filed an amended SC 13G/A on January 25, 2024, indicating its ownership of TG Therapeutics Inc common stock as
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX